475 related articles for article (PubMed ID: 21601901)
21. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.
Khan AM; Dutta P; Sarmah CK; Baruah NK; Das S; Pathak AK; Sarmah P; Hussain ME; Mahanta J
J Vector Borne Dis; 2015 Dec; 52(4):314-20. PubMed ID: 26714512
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
[TBL] [Abstract][Full Text] [Related]
26. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
27. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
28. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
[TBL] [Abstract][Full Text] [Related]
29. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya.
Njenga SM; Wamae CN; Njomo DW; Mwandawiro CS; Molyneux DH
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):1017-24. PubMed ID: 18550135
[TBL] [Abstract][Full Text] [Related]
30. Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Dash AP; Tyagi BK
Bull World Health Organ; 2007 Feb; 85(2):138-45. PubMed ID: 17308735
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
Supali T; Ismid IS; Rückert P; Fischer P
Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
[TBL] [Abstract][Full Text] [Related]
32. Interruption of annual single dose DEC regimen administration: impact on Wuchereria bancrofti microfilaraemia, vector infection and infectivity rates.
Dixit V; Gupta AK; Prasad GB
J Commun Dis; 2009 Mar; 41(1):25-31. PubMed ID: 19886172
[TBL] [Abstract][Full Text] [Related]
33. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
34. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
[TBL] [Abstract][Full Text] [Related]
35. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
El Setouhy M; Ramzy RM; Ahmed ES; Kandil AM; Hussain O; Farid HA; Helmy H; Weil GJ
Am J Trop Med Hyg; 2004 Feb; 70(2):191-6. PubMed ID: 14993632
[TBL] [Abstract][Full Text] [Related]
36. Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India.
Ramaiah KD; Vanamail P
Trans R Soc Trop Med Hyg; 2013 May; 107(5):293-300. PubMed ID: 23442572
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
[TBL] [Abstract][Full Text] [Related]
38. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
[TBL] [Abstract][Full Text] [Related]
39. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
40. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
Weil GJ; Kastens W; Susapu M; Laney SJ; Williams SA; King CL; Kazura JW; Bockarie MJ
PLoS Negl Trop Dis; 2008; 2(12):e344. PubMed ID: 19065257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]